Stock screenerAll disclosures →
EDGAR →
RPRX
Conviction 83HealthcareScan · Thu, Jun 25, 2026Bullish harami
RPRX$54.68+0.74%
ResistanceSupportVol 14Insider sell2
2
Vol MA14 4.16M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price54.68
Change+0.74%
Gap+0.18%
Rel volume1.38×
Avg volume4.81M
Avg $ vol263.86M
SMA 2054.67
SMA 5052.50
SMA 20043.71
Price vs 50+4.15%
Price vs 200+25.10%
MA stackbullish
50/200 cross—
Supertrendup · 51.81
RSI (14)54
MACD hist-0.20
MACD cross—
Stoch %K / %D66 / 68
ADX (14)36
+DI / −DI21 / 19
RSI divergenceBearish
MACD divergenceBearish
ATR %+2.54%
ADR %2.61%
52w high55.87
52w low34.90
From 52w high-2.13%
Above 52w low+56.68%
New 52w highNo
SqueezeOn · 1d
Bollinger width5.44%
%B0.50
Donchian pos65.98%
Donchian high56.50
Donchian low51.15
AVWAP (52w high)54.34
vs AVWAP high+0.63%
AVWAP (52w low)43.49
vs AVWAP low+25.73%
OBV trendUp
Chaikin MF (20)0.17
Today vs 20d1.38×
Avg vol (14d)4.16M
Avg vol (20d)4.81M
Avg $ vol (20d)263.86M
Market cap21.22B
RS 3m (vs SPY)+6.86%
RS 6m (vs SPY)+32.89%
RS line new highNo
Trend template8/8
Technical rank81.7
1 week+1.82%
1 month+1.52%
3 months+16.27%
6 months+40.71%
1 year+51.30%
YTD+40.71%
P/E27.53
P/B2.14
P/S8.92
P/FCF—
EPS1.78
Div yield—
ROE7.76%
ROA3.89%
Debt/Eq0.90
Current2.66
EV/EBITDA—
Gross margin—
Net margin32.42%
Rev growth5.06%
EPS growth-10.25%
Price target59.43
Target upside8.69%
Analyst ratingBuy
Institutional84.26%
Ent. value29.59B
Revenue630.58M
Net income294.69M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out443.27M
Employees100
ListedTue, Jun 16, 2020
Free float406.4M
Float %94.9%
Short interest11.59M
Days to cover2.5d
Short volume60.1%
Squeeze score37 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast$1.27 · 4 est
Last EPS vs est$1.30 vs $1.22
Last surprise+6.6% beat
Setup gradeA
Conviction83 / 100
Pattern quality—
Tech rank81.7 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish harami
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RPRX
No recent disclosed trades by Congress in RPRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RPRX · 6 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Urist Marshall EVP, Research & Investments · Class A Ordinary Shares · 2026-06-24 | Sell | 9.1K | $502K | 2026-06-24 | 2026-06-25 |
Hite Christopher EVP & Chairman, Partnering · Class A Ordinary Shares · 2026-06-23 | Sell | 32.41K | $1.8M | 2026-06-23 | 2026-06-25 |
Hite Christopher EVP & Chairman, Partnering · Class A Ordinary Shares · 2026-06-23 | Sell | 117.59K | $6.4M | 2026-06-23 | 2026-06-25 |
Engelbert Catherine M. Director · Class A Ordinary Shares · 2026-06-05 | Grant | 4.54K | $0 | 2026-06-05 | 2026-06-08 |
Ho Carole Director · Class A Ordinary Shares · 2026-06-05 | Grant | 4.54K | $0 | 2026-06-05 | 2026-06-08 |
Ho Carole Director · Class A Ordinary Shares · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-08 |
Bassler Bonnie L Director · Class A Ordinary Shares · 2026-06-05 | Grant | 4.54K | $0 | 2026-06-05 | 2026-06-08 |
Norden Gregory Director · Class A Ordinary Shares · 2026-06-05 | Grant | 4.54K | $0 | 2026-06-05 | 2026-06-08 |
HODGSON DAVID C Director · Class A Ordinary Shares · 2026-06-05 | Grant | 4.54K | $0 | 2026-06-05 | 2026-06-08 |
LOVE TED W Director · Class A Ordinary Shares · 2026-06-05 | Grant | 4.54K | $0 | 2026-06-05 | 2026-06-08 |
SEC filings
EDGAR filings in RPRX · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.